Exagen
Develops AVISE tests for diagnosis and monitoring of autoimmune disease.
$7.39
After-hours close+0.01 (+0.14%)
At close$7.38(−1.86%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 40.04%9.67M sharesInsiders 4.89%1.18M sharesOther 55.07%13.30M shares
Shares outstanding 24.16M · Float 13.81M · 57.2% free float
A Form 4 total here can count shares the filer formally disclaims — an award voted by proxy, for instance — which the holder's own Schedule 13D/G excludes, so where the two disagree the schedule's smaller figure is used.
Institutions13F, as of Mar 31, 2026
61 holders · 9.67M shares · 8 new positions · 33 increased · 22 reduced · 27 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Balyasny Asset Management L.P. | 796.6K | 3.30% | −122.6K | May 15, 2026 |
| Wexford Capital LP | 792.9K | 3.28% | +326.1K | May 15, 2026 |
| Acadian Asset Management LLC | 689.1K | 2.85% | +274.7K | May 13, 2026 |
| Vanguard Capital Management LLC | 678.7K | 2.81% | +678.7Knew | May 15, 2026 |
| Nano Cap New Millennium Growth Fund L P | 585.0K | 2.42% | +335.0K | May 15, 2026 |
| Silvercrest Asset Management Group LLC | 537.9K | 2.23% | −60.1K | May 15, 2026 |
| Kennedy Capital Management LLC | 493.7K | 2.04% | +13.6K | May 13, 2026 |
| Fourworld Capital Management LLC | 440.0K | 1.82% | +167.0K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Chernett Jorey | 9.90% | 2.41M | 13G | May 20, 2026 ↗ |
| NMSIC Co-Investment Fund, L.P. | 6.04% | 1.37M | 13G | Feb 11, 2026 ↗ |
| Parian Ultreia LP | 5.30% | 1.29M | 13G | May 27, 2026 ↗ |
| Cowen Financial Products LLC | 5.00% | 891.4K | 13G | May 12, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| NMSIC Co-Investment Fund, L.P. | 10 percent owner | 1.37M | 5.67% | Mar 27, 2025 |
| John Aballi | director, officer: President and CEO | 839.8K | 3.48% | Mar 16, 2026 |
| Jeffrey G. Black | officer: Chief Financial Officer | 342.4K | 1.42% | Mar 16, 2026 |
5 ten-percent owners hold 7.04M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 5 people have not refiled in the last 18 months (639.9K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Mar 3, 2026 | John Aballidirector, officer: President and CEO | Sale | 15,698 | $3.62 | 687,299 |
| Feb 24, 2026 | Jeffrey G. Blackofficer: Chief Financial Officer | Sale | 1,584 | $3.61 | 267,442 |
| Feb 24, 2026 | John Aballidirector, officer: President and CEO | Sale | 11,430 | $3.61 | 702,997 |
| Oct 16, 2025 | John Aballidirector, officer: President and CEO | Sale | 31,787 | $11.82 | 714,427 |
| Sep 2, 2025 | Jeffrey G. Blackofficer: Chief Financial Officer | Sale | 20,466 | $9.79 | 269,026 |
CongressHouse and Senate disclosures
Not reported.